Reciprocal interaction between lung mesenchymal and epithelial cells is essential for normal lung development and homeostasis. Therefore, alterations in lung mesenchymal cell biology will have a significant impact on both fetal lung formation and postnatal lung injury repair, resulting in the pathogenesis of many lung diseases. Although several sophisticated mouse genetic approaches have been obtained to study lung epithelial cell biology, the lack of lung mesenchymal cell-specific mouse genetic approaches to date has become a critical barrier to the field of lung research. We hypothesize that Tbx4 lung enhancer driven rtTA (reverse tetracycline- dependent transactivator) transgenic mouse line (Tbx4-rtTA) can be used to make a novel lung mesenchymal- specific Tet-On genetic system to study lung mesenchymal cell signaling in lung development and injury repair. Thus, combination of Tbx4-rtTA and TetO promoter driven dominant-negative TGF-? receptor II (dnT2RII) transgenic lines will provide a unique tool to study TGF-? signaling specifically in lung mesenchyme and its impact on lung development in vivo.
Specific Aim 1. To develop and characterize a lung-mesenchymal cell-specific Tet-On genetic system. A 5.5 kb lung enhancer DNA element of Tbx4 gene will be used to make the Tbx4-rtTA transgenic mice. The lung mesenchymal localization of rtTA transgenic expression at different ages will then be verified. Furthermore, a lung mesenchymal cell-specific Tet-On genetic system will be generated and tested in mice by crossing Tbx4-rtTA and TetO-Cre mice with a floxed-mT-mG fluorescence protein reporter system.
Specific Aim 2. To dissect the regulatory functions of TGF-? signaling in developing lung mesenchymal cells in vivo using the established lung mesenchymal Tet-On genetic approach. We will apply the newly developed lung mesenchymal Tet-On system to characterize TGF-? signaling in lung mesenchymal cells, as TGF- ? signaling plays extremely important roles in regulating lung development, injury repair, and lung diseases. By generating a Tbx4-rtTA/TetO-dnT2RII mouse line, lung mesenchymal-specific TGF-? signaling can be reversibly inhibited at various levels and stages in vivo through dnT2RII induction. The roles of mesenchymal TGF-? signaling in regulating lung development will then be dissected. Development of these novel genetic approaches has the potential to substantially extend current knowledge of lung mesenchymal cell biology and its relationship to lung diseases. Furthermore, by applying this system to lung mesenchymal TGF-? signaling research, we will be able to dissect the genetic dosages and time windows of TGF-? signaling in regulating lung development and maturation. Successful establishment of these unique genetic systems will provide powerful tools to define the role of mesenchymal signaling in lung development and homeostasis, and in the pathophysiology of lung diseases. Additionally, new therapeutic targets may be identified.

Public Health Relevance

This proposed project will develop a novel genetic approach to specifically target lung mesenchymal cells in mouse model. Successful establishment of this methodology and its application to study TGF-? signaling in developing lung mesenchymal cells have the potential to substantially advance our research in lung mesenchymal cell biology. Moreover, these genetic tool and mouse models will help to break through the critical barrier in understanding the pathogenic mechanisms of several lung diseases including asthma and pulmonary fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL109932-01
Application #
8176683
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Blaisdell, Carol J
Project Start
2011-08-01
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$240,000
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
052277936
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Buckley, Susan; Shi, Wei; Xu, Wei et al. (2015) Increased alveolar soluble annexin V promotes lung inflammation and fibrosis. Eur Respir J 46:1417-29
Luo, Yongfeng; Xu, Wei; Chen, Hui et al. (2015) A novel profibrotic mechanism mediated by TGF?-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells. J Pathol 236:384-94
Luo, Yongfeng; El Agha, Elie; Turcatel, Gianluca et al. (2015) Mesenchymal adenomatous polyposis coli plays critical and diverse roles in regulating lung development. BMC Biol 13:42
Zhang, Wenming; Menke, Douglas B; Jiang, Meisheng et al. (2013) Spatial-temporal targeting of lung-specific mesenchyme by a Tbx4 enhancer. BMC Biol 11:111
Xu, Wei; Liu, Chengyu; Kaartinen, Vesa et al. (2013) TACE in perinatal mouse lung epithelial cells promotes lung saccular formation. Am J Physiol Lung Cell Mol Physiol 305:L953-63
Turcatel, Gianluca; Rubin, Nicole; Menke, Douglas B et al. (2013) Lung mesenchymal expression of Sox9 plays a critical role in tracheal development. BMC Biol 11:117
Xu, Bing; Chen, Hui; Xu, Wei et al. (2012) Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice. Am J Physiol Lung Cell Mol Physiol 303:L89-96
Xu, Wei; Lan, Qin; Chen, Maogen et al. (2012) Adoptive transfer of induced-Treg cells effectively attenuates murine airway allergic inflammation. PLoS One 7:e40314